Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;41(1):97-130.
doi: 10.1007/s10930-021-10029-2. Epub 2022 Feb 3.

16S rRNA Methyltransferases as Novel Drug Targets Against Tuberculosis

M R Salaikumaran  1 , Veena P Badiger  1 , V L S Prasad Burra  2
Affiliations
Review

16S rRNA Methyltransferases as Novel Drug Targets Against Tuberculosis

M R Salaikumaran et al. Protein J. 2022 Feb.

Abstract

Tuberculosis (TB) is an airborne infectious disease caused by Mycobacterium tuberculosis (M.tb) whose natural history traces back to 70,000 years. TB remains a major global health burden. Methylation is a type of post-replication, post-transcriptional and post-translational epi-genetic modification involved in transcription, translation, replication, tissue specific expression, embryonic development, genomic imprinting, genome stability and chromatin structure, protein protein interactions and signal transduction indicating its indispensable role in survival of a pathogen like M.tb. The pathogens use this epigenetic mechanism to develop resistance against certain drug molecules and survive the lethality. Drug resistance has become a major challenge to tackle and also a major concern raised by WHO. Methyltransferases are enzymes that catalyze the methylation of various substrates. None of the current TB targets belong to methyltransferases which provides therapeutic opportunities to develop novel drugs through studying methyltransferases as potential novel targets against TB. Targeting 16S rRNA methyltransferases serves two purposes simultaneously: a) translation inhibition and b) simultaneous elimination of the ability to methylate its substrates hence stopping the emergence of drug resistance strains. There are ~ 40 different rRNA methyltransferases and 13 different 16S rRNA specific methyltransferases which are unexplored and provide a huge opportunity for treatment of TB.

Keywords: 16S rRNA; Drug target; Methyltransferases; SAM-dependent methyltransferases; Tuberculosis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Churchyard G, Kim P, Shah NS, Rustomjee R, Gandhi N, Mathema B et al (2017) What we know about tuberculosis transmission: an overview. J Infect Dis 216:S629–S635
    1. Witek MA, Kuiper EG, Minten E, Crispell EK, Conn GL (2017) A novel motif for S-Adenosyl-l-methionine binding by the ribosomal RNA Methyltransferase TlyA from Mycobacterium tuberculosis. J Biol Chem. https://doi.org/10.1074/jbc.m116.752659 - DOI - PubMed
    1. Osterman IA, Dontsova OA, Sergiev PV (2020) rRNA methylation and antibiotic resistance. Biochemistry 85:1335–1349 - PubMed
    1. Sergiev PV, Aleksashin NA, Chugunova AA, Polikanov YS, Dontsova OA (2018) Structural and evolutionary insights into ribosomal RNA methylation. Nat Chem Biol 14:226–235 - PubMed
    1. WHO | The End TB Strategy. 2018 [cited 24 Aug 2019]. Available: http://www.who.int/tb/strategy/en/ .

Publication types

MeSH terms

LinkOut - more resources

-